Biotechnology Industry Returns
Track and compare the best performing companies in the Biotechnology industry. Find top stocks ranked by their compound annual growth rate (CAGR).
Top Performer (5Y)
Verona Pharma plc
Industry Rank
#154
1 Month Trend
92.61%
Positive Returns
16%
| # | Name | Price | 1m | 3m | 5Y CAGR | Market Cap | Country |
|---|---|---|---|---|---|---|---|
| 1 | V VRNA Verona Pharma plc | $84.34 | 27.29% | 30.46% | 72.01% | $6.5B | US |
| 2 | C CLDX Celldex Therapeutics, Inc. | $21.35 | 9.37% | 3.29% | 47.13% | $1.4B | US |
| 3 | A ADMA ADMA Biologics, Inc. | $20.61 | -2.78% | 21.09% | 46.47% | $4.7B | US |
| 4 | C CPRX Catalyst Pharmaceuticals, Inc. | $25.87 | 13.66% | 17.81% | 41.41% | $3.0B | US |
| 5 | C CORT Corcept Therapeutics Incorporated | $69.60 | -2.49% | 25.63% | 36.41% | $7.9B | US |
| 6 | B BRTX BioRestorative Therapies, Inc. | $1.80 | -0.86% | 16.45% | 35.19% | $11.9M | US |
| 7 | O OCGN Ocugen, Inc. | $1.06 | 53.85% | 73.77% | 30.15% | $217.0M | US |
| 8 | M MRUS Merus N.V. | $56.21 | 31.42% | 22.01% | 28.73% | $2.9B | US |
| 9 | P PTGX Protagonist Therapeutics, Inc. | $54.38 | 23.82% | 41.80% | 27.36% | $2.8B | US |
| 10 | R RYTM Rhythm Pharmaceuticals, Inc. | $68.11 | 12.17% | 34.10% | 26.85% | $3.9B | US |
| 11 | C CAPR Capricor Therapeutics, Inc. | $14.23 | 104.16% | 11.09% | 24.98% | $468.5M | US |
| 12 | M MNKD MannKind Corporation | $4.38 | -5.40% | -12.05% | 24.93% | $1.4B | US |
| 13 | V VCEL Vericel Corporation | $43.30 | 3.42% | -12.63% | 24.68% | $2.2B | US |
| 14 | Z ZVRA Zevra Therapeutics, Inc. | $9.26 | 18.87% | 14.32% | 24.32% | $481.7M | US |
| 15 | K KRYS Krystal Biotech, Inc. | $136.94 | -0.17% | -23.89% | 23.88% | $3.8B | US |
| 16 | N NAGE Niagen Bioscience, Inc. | $12.95 | 40.15% | 68.18% | 22.91% | $864.4M | US |
| 17 | C CRIS Curis, Inc. | $2.37 | 12.86% | -18.56% | 22.49% | $22.3M | US |
| 18 | I INSM Insmed Incorporated | $73.62 | 12.17% | -1.70% | 21.24% | $12.4B | US |
| 19 | X XENE Xenon Pharmaceuticals Inc. | $31.64 | -10.97% | -13.32% | 21.19% | $2.4B | US |
| 20 | A ARGX argenx SE | $585.93 | 2.95% | -1.39% | 21.19% | $34.9B | US |
| 21 | I IDYA IDEAYA Biosciences, Inc. | $21.73 | 19.53% | 17.71% | 19.67% | $1.6B | US |
| 22 | M MIRM Mirum Pharmaceuticals, Inc. | $46.38 | 2.52% | 6.72% | 19.60% | $2.2B | US |
| 23 | M MDGL Madrigal Pharmaceuticals, Inc. | $278.23 | -7.12% | -16.05% | 19.20% | $6.4B | US |
| 24 | C CRMD CorMedix Inc. | $13.98 | 16.21% | 30.53% | 18.96% | $851.9M | US |
| 25 | A ALNY Alnylam Pharmaceuticals, Inc. | $300.83 | 16.44% | 23.03% | 18.20% | $38.0B | US |
| 26 | H HALO Halozyme Therapeutics, Inc. | $54.25 | -19.90% | -11.04% | 17.80% | $6.5B | US |
| 27 | B BNTX BioNTech SE | $108.49 | 14.47% | -0.27% | 17.66% | $23.5B | US |
| 28 | T TGTX TG Therapeutics, Inc. | $40.06 | 18.31% | 4.21% | 17.47% | $5.0B | US |
| 29 | L LQDA Liquidia Corporation | $18.14 | 18.18% | 22.40% | 16.08% | $1.4B | US |
| 30 | C CRNX Crinetics Pharmaceuticals, Inc. | $33.01 | 0.95% | -0.81% | 15.62% | $2.9B | US |
| 31 | E EXEL Exelixis, Inc. | $43.03 | 17.89% | 11.53% | 13.74% | $12.2B | US |
| 32 | M MDXG MiMedx Group, Inc. | $6.49 | -12.53% | -17.74% | 13.35% | $1.1B | US |
| 33 | D DNTH Dianthus Therapeutics, Inc. | $18.85 | -8.58% | -21.56% | 13.08% | $620.7M | US |
| 34 | B BPMC Blueprint Medicines Corporation | $127.85 | 29.46% | 46.75% | 11.47% | $6.5B | US |
| 35 | V VRTX Vertex Pharmaceuticals Incorporated | $450.50 | 4.86% | -7.74% | 11.20% | $112.6B | US |
| 36 | A ABUS Arbutus Biopharma Corporation | $3.48 | 5.45% | 5.14% | 11.17% | $594.7M | US |
| 37 | I IMMP Immutep Limited | $1.86 | 0.00% | 5.68% | 9.53% | $284.6M | US |
| 38 | C CYTK Cytokinetics, Incorporated | $32.30 | -0.55% | -25.63% | 8.88% | $3.7B | US |
| 39 | L LYRA Lyra Therapeutics, Inc. | $24.28 | 25729.79% | 12545.83% | 8.79% | $6.9M | US |
| 40 | I INVA Innoviva, Inc. | $21.58 | 16.15% | 22.34% | 8.67% | $1.2B | US |
| 41 | M MDWD MediWound Ltd. | $21.60 | 23.71% | 27.58% | 8.53% | $218.3M | US |
| 42 | O ONC BeiGene, Ltd. | $255.86 | 8.44% | 3.56% | 8.16% | $25.1B | US |
| 43 | I ICCC ImmuCell Corporation | $6.53 | 27.00% | 27.75% | 7.73% | $48.0M | US |
| 44 | A AXSM Axsome Therapeutics, Inc. | $111.91 | 2.80% | -8.40% | 6.80% | $5.4B | US |
| 45 | L LGND Ligand Pharmaceuticals Incorporated | $105.99 | 3.39% | -7.70% | 6.65% | $2.0B | US |
| 46 | A ATYR aTyr Pharma, Inc. | $5.38 | 61.08% | 58.24% | 6.32% | $306.6M | US |
| 47 | I INMB INmune Bio, Inc. | $7.62 | 7.48% | -4.99% | 6.32% | $184.8M | US |
| 48 | B BBIO BridgeBio Pharma, Inc. | $38.62 | 10.82% | 22.33% | 5.30% | $6.3B | US |
| 49 | A ASND Ascendis Pharma A/S | $173.06 | 8.58% | 18.75% | 5.10% | $9.6B | US |
| 50 | C CRDF Cardiff Oncology, Inc. | $3.88 | 47.53% | 0.52% | 4.80% | $189.3M | US |
Industry Analysis
The Biotechnology industry consists of 374 companies tracked by MultiMarketCap.com, with a combined market capitalization of $664.7B.
The average 5y-year Compound Annual Growth Rate (CAGR) for the industry is -13.48%, which indicates challenges within this sector. Only 16% of companies in this industry have shown positive returns over this period.
The top performer in the Biotechnology industry is Verona Pharma plc (VRNA) with a 5y-year CAGR of 72.01%. On the other end, Biodexa Pharmaceuticals Plc (BDRX) has shown the lowest returns with a CAGR of -88.62%.
In terms of recent performance, the industry has shown an average 1-month return of 92.61%, indicating a positive short-term trend.
Compared to other industries, the Biotechnology sector ranks #154 out of 157 industries tracked by MultiMarketCap.com in terms of 5y-year returns.